The elucidation of this novel pathway involving integrin αv-mediated regulation of cyclin D2, p53 and netrin-1 will provide an innovative therapeutic tool for increasing the proliferative and migratory potential of neural stem cells during stroke. Here, CCND2 is linked to stroke disorder.